Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Monday ​that a late-stage trial testing ‌its multiple sclerosis drug ...

HCW11-040 expands and activates human peripheral blood lymphocytes (PBMCs) and memory T cells significantly better than pembrolizumab alone. HCW11-040 exhibits significantly better anti-tumor activity ...

It's difficult to put an exact price tag on how much index funds have saved investors since their creation in 1975. But it's ...

Q3 2025 Earnings Call Transcript November 10, 2025 Pagaya Technologies Ltd. misses on earnings expectations. Reported EPS is ...

You’ve probably felt it before: that euphoric feeling after biting into one of your favorite foods. Your eyes roll back, you ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced ...

SJR10 urges Congress to support federal reforms that will finally open the door to psychedelic-assisted therapies.

However, even in a market with generic competitors, Xywav offers a differentiated profile, and we will partner with payers to ...

The difference between the growth in the number of experiences booked Mike Noonan: and growth in revenue continues to be ...